Tag:

Nanotherapeutics

Latest Headlines

Latest Headlines

Baxter backs away from vaccines with Vero tech sale to Nanotherapeutics

December 15, 2014 | By
Baxter, prepping for a biopharma spinoff, has already revealed that vaccines won't figure into its plans going forward. And Monday, it took it second step to exit the space with a sale of its Vero technology and related assets.
Related Tags
Press Releases
  • AveXis Appoints Sean P. Nolan as Chief Executive Officer
  • OncoCyte (BTX) Appoints William Annett as CEO
  • Roche to provide HIV diagnostic solutions to Global Fund
  • Cynvenio's CLIA Lab and Venture-Backed Cure Forward Partner to Empower Cancer Patients With Access to Genomic Information from Standard Whole Blood Draw
  • Teva and Microchips Biotech Announce Partnership to Enhance Patient Outcomes through Digital Drug Delivery Technology
  • More Press Releases
Sponsored Links